Standard

Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors : synthesis and inhibitory profile. / Sharonova, Tatiana; Zhmurov, Petr; Kalinin, Stanislav; Nocentini, Alessio; Angeli, Andrea; Ferraroni, Marta; Korsakov, Mikhail; Supuran, Claudiu T.; Krasavin, Mikhail.

в: Journal of Enzyme Inhibition and Medicinal Chemistry, Том 37, № 1, 16.03.2022, стр. 857-865.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Sharonova, T, Zhmurov, P, Kalinin, S, Nocentini, A, Angeli, A, Ferraroni, M, Korsakov, M, Supuran, CT & Krasavin, M 2022, 'Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile', Journal of Enzyme Inhibition and Medicinal Chemistry, Том. 37, № 1, стр. 857-865. https://doi.org/10.1080/14756366.2022.2051023

APA

Vancouver

Author

Sharonova, Tatiana ; Zhmurov, Petr ; Kalinin, Stanislav ; Nocentini, Alessio ; Angeli, Andrea ; Ferraroni, Marta ; Korsakov, Mikhail ; Supuran, Claudiu T. ; Krasavin, Mikhail. / Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors : synthesis and inhibitory profile. в: Journal of Enzyme Inhibition and Medicinal Chemistry. 2022 ; Том 37, № 1. стр. 857-865.

BibTeX

@article{b724db2b9d634a4ea5f8eb3d7e5db091,
title = "Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile",
abstract = "A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.",
keywords = "Carbonic anhydrase, co-operative fragment screening, solubility, sulfamides, zinc-binding groups, Humans, Structure-Activity Relationship, Drug Discovery, Dose-Response Relationship, Drug, Carbonic Anhydrase Inhibitors/chemical synthesis, Carbonic Anhydrases/metabolism, Molecular Structure, Sulfonamides/chemical synthesis, Isoenzymes/antagonists & inhibitors, DESIGN, SULFONAMIDES, OF-THE-ART, FAMOTIDINE, ISOZYME-II",
author = "Tatiana Sharonova and Petr Zhmurov and Stanislav Kalinin and Alessio Nocentini and Andrea Angeli and Marta Ferraroni and Mikhail Korsakov and Supuran, {Claudiu T.} and Mikhail Krasavin",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",
year = "2022",
month = mar,
day = "16",
doi = "10.1080/14756366.2022.2051023",
language = "English",
volume = "37",
pages = "857--865",
journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",
issn = "1475-6366",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors

T2 - synthesis and inhibitory profile

AU - Sharonova, Tatiana

AU - Zhmurov, Petr

AU - Kalinin, Stanislav

AU - Nocentini, Alessio

AU - Angeli, Andrea

AU - Ferraroni, Marta

AU - Korsakov, Mikhail

AU - Supuran, Claudiu T.

AU - Krasavin, Mikhail

N1 - Publisher Copyright: © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

PY - 2022/3/16

Y1 - 2022/3/16

N2 - A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.

AB - A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.

KW - Carbonic anhydrase

KW - co-operative fragment screening

KW - solubility

KW - sulfamides

KW - zinc-binding groups

KW - Humans

KW - Structure-Activity Relationship

KW - Drug Discovery

KW - Dose-Response Relationship, Drug

KW - Carbonic Anhydrase Inhibitors/chemical synthesis

KW - Carbonic Anhydrases/metabolism

KW - Molecular Structure

KW - Sulfonamides/chemical synthesis

KW - Isoenzymes/antagonists & inhibitors

KW - DESIGN

KW - SULFONAMIDES

KW - OF-THE-ART

KW - FAMOTIDINE

KW - ISOZYME-II

UR - http://www.scopus.com/inward/record.url?scp=85126648518&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/d1d8281d-b314-3daf-abe0-c6e8fd57ccf0/

U2 - 10.1080/14756366.2022.2051023

DO - 10.1080/14756366.2022.2051023

M3 - Article

C2 - 35296197

AN - SCOPUS:85126648518

VL - 37

SP - 857

EP - 865

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

SN - 1475-6366

IS - 1

ER -

ID: 94010611